Trade Medpace Holdings Inc - MEDP CFD
Add to favourite- Summary
- Historical Data
Spread | 0.40 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 312.11 |
Open | 300.4 |
1-Year Change | -25.65% |
Day's Range | 289.12 - 305.59 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2025 | 312.11 | -2.79 | -0.89% | 314.90 | 316.64 | 311.55 |
Mar 27, 2025 | 316.41 | -0.13 | -0.04% | 316.54 | 319.33 | 312.96 |
Mar 26, 2025 | 317.69 | -6.26 | -1.93% | 323.95 | 324.53 | 315.32 |
Mar 25, 2025 | 324.12 | -3.76 | -1.15% | 327.88 | 331.12 | 320.70 |
Mar 24, 2025 | 330.28 | 7.34 | 2.27% | 322.94 | 330.79 | 322.43 |
Mar 21, 2025 | 323.80 | 7.55 | 2.39% | 316.25 | 324.09 | 309.95 |
Mar 20, 2025 | 319.57 | -0.38 | -0.12% | 319.95 | 324.94 | 319.22 |
Mar 19, 2025 | 327.34 | 5.37 | 1.67% | 321.97 | 328.72 | 319.95 |
Mar 18, 2025 | 322.70 | -2.25 | -0.69% | 324.95 | 325.69 | 321.89 |
Mar 17, 2025 | 325.81 | 2.93 | 0.91% | 322.88 | 329.88 | 322.88 |
Mar 14, 2025 | 324.67 | 2.72 | 0.84% | 321.95 | 328.10 | 318.05 |
Mar 13, 2025 | 317.87 | -4.13 | -1.28% | 322.00 | 325.32 | 317.71 |
Mar 12, 2025 | 324.65 | -3.30 | -1.01% | 327.95 | 330.06 | 320.99 |
Mar 11, 2025 | 325.80 | -11.58 | -3.43% | 337.38 | 338.32 | 324.74 |
Mar 10, 2025 | 337.26 | 9.45 | 2.88% | 327.81 | 347.20 | 327.81 |
Mar 7, 2025 | 332.68 | 9.26 | 2.86% | 323.42 | 333.26 | 322.94 |
Mar 6, 2025 | 325.19 | 1.99 | 0.62% | 323.20 | 330.92 | 323.20 |
Mar 5, 2025 | 328.34 | 6.39 | 1.98% | 321.95 | 330.40 | 321.95 |
Mar 4, 2025 | 324.02 | 6.07 | 1.91% | 317.95 | 328.04 | 316.75 |
Mar 3, 2025 | 319.12 | -6.83 | -2.10% | 325.95 | 328.69 | 318.97 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Medpace Holdings Company profile
About Medpace Holdings Inc
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Medpace Holdings Inc revenues increased 23% to $1.14B. Net income applicable to common stockholders increased 25% to $181.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 35% to $5.1M (expense), Stock-based Compensation in SGA decrease of 15% to $5.1M (expense).
Industry: | Biotechnology & Medical Research (NEC) |
5375 Medpace Way
CINCINNATI
OHIO 45227-1543
US
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com